STOCK TITAN
  1. Home
  2. Sec-filings
  3. BWAY
  4. [Form 4] Brainsway Ltd. Insider Trading Activity

Brainsway (BWAY) director sells 17,980 shares, retains 12,500 including RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Brainsway Ltd. director Michal Ety Mitrany Rayten reported open-market sales of a total of 17,980 Ordinary Shares over two days. The shares were sold at prices of NIS 45.5588 and NIS 44.7516 per share. Following these transactions, she holds 12,500 Ordinary Shares, including 6,250 unvested RSUs that vest quarterly until March 5, 2028. The Ordinary Shares may also be held as American Depositary Shares, each currently representing one Ordinary Share.

Positive

  • None.

Negative

  • None.
Insider Mitrany Rayten Michal Ety
Role null
Sold 17,980 shs ($0.00)
Type Security Shares Price Value
Sale Ordinary Shares 7,980 $0.00 --
Sale Ordinary Shares 10,000 $0.00 --
Holdings After Transaction: Ordinary Shares — 12,500 shares (Direct, null)
Footnotes (1)
  1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 45.5588 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. The sale price was NIS 44.7516 per share.
Total shares sold 17,980 shares Net open-market sales reported in Form 4
Shares sold on May 25, 2026 10,000 shares Ordinary Shares, open-market sale
Shares sold on May 26, 2026 7,980 shares Ordinary Shares, open-market sale
Sale price May 25, 2026 NIS 44.7516/share Ordinary Shares sale price from footnote
Sale price May 26, 2026 NIS 45.5588/share Ordinary Shares sale price from footnote
Shares held after transactions 12,500 shares Includes Ordinary Shares and 6,250 unvested RSUs
Unvested RSUs 6,250 RSUs Vest quarterly until March 5, 2028
American Depositary Shares financial
"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
restricted stock units ("RSUs") financial
"This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028,"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mitrany Rayten Michal Ety
(Last)(First)(Middle)
16 HARTUM STREET, RAD TOWER, 14TH FLOOR
HAR HAHOTZVIM
(Street)
JERUSALEM9777516
(City)(State)(Zip)
ISRAEL
(Country)		2. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/25/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares(1)05/25/2026S10,000D(2)20,480(3)D
Ordinary Shares(1)05/26/2026S7,980D(4)12,500(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
2. The sale price was NIS 45.5588 per share.
3. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share.
4. The sale price was NIS 44.7516 per share.
/s/ Ety Mitrany05/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Brainsway (BWAY) disclose in this Form 4?

Brainsway disclosed that director Michal Ety Mitrany Rayten sold 17,980 Ordinary Shares in open-market transactions. These sales occurred on two consecutive days and were reported as non-derivative transactions involving the company’s Ordinary Shares listed on the market.

How many Brainsway (BWAY) shares did the director sell and at what prices?

The director sold 10,000 Ordinary Shares at NIS 44.7516 per share and 7,980 Ordinary Shares at NIS 45.5588 per share. Both transactions are described as open-market or private sale transactions involving Brainsway’s Ordinary Shares.

How many Brainsway (BWAY) shares does the director hold after these sales?

After the reported sales, the director holds 12,500 Ordinary Shares. This figure includes 6,250 unvested restricted stock units (RSUs), each representing a contingent right to receive one Ordinary Share of Brainsway as the units vest over time.

What are the terms of the Brainsway (BWAY) RSUs mentioned in the Form 4?

The Form 4 states the director has RSUs to receive 6,250 Ordinary Shares that vest quarterly until March 5, 2028. Each RSU represents a contingent right to receive one Ordinary Share, adding to the director’s potential future equity holdings.

Were the Brainsway (BWAY) insider transactions direct or indirect holdings?

The transactions are reported as direct ownership, indicated by the ownership code "D" for each sale. The filing does not attribute the shares to any trust, partnership, or other entity, so they are treated as directly held by the reporting director.